Do I need an in-person exam for Ozempic in Pennsylvania?

If you’ve been wondering whether you can legally obtain medications like Wegovy, Ozempic, or Mounjaro through telehealth, you’re not alone. As obesity rates continue to climb and breakthrough GLP-1 medications show remarkable results, more Americans are turning to online healthcare for weight management solutions. The short answer is yes—but there are important things you need to know about safety, regulations, and what to expect.

Understanding Telehealth for Weight Loss: The Basics

Telehealth has transformed how we access healthcare, and weight management is no exception. Unlike controlled substances that face strict federal regulations, GLP-1 medications for weight loss are not controlled substances. This means there’s no federal law requiring you to see a doctor in person before getting a prescription for medications like Wegovy or Mounjaro.

However, ‘legal’ doesn’t mean ‘easy’ or ‘right for everyone.’ Getting these medications through telehealth still requires a thorough medical evaluation, ongoing monitoring, and meeting specific clinical criteria. Reputable providers won’t simply hand out prescriptions—they’ll ensure you’re a safe candidate and that the treatment aligns with your health goals.

What Are GLP-1 Medications?

GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking a hormone your body naturally produces to regulate blood sugar and appetite. The three most commonly prescribed options include:

• Wegovy (semaglutide 2.4mg): FDA-approved specifically for chronic weight management
• Ozempic (semaglutide 0.5–1mg): FDA-approved for type 2 diabetes, often prescribed off-label for weight loss
• Mounjaro (tirzepatide): FDA-approved for diabetes; its weight-loss version, Zepbound, launched in late 2023

These weekly injections can help you feel fuller longer, reduce cravings, and achieve meaningful weight loss when combined with lifestyle changes.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Regulations: What You Need to Know

The federal landscape for telehealth prescribing has evolved significantly, especially since the COVID-19 pandemic. Here’s where things stand as of late 2025:

The Ryan Haight Act Exception

The Ryan Haight Act, which typically requires an in-person exam before prescribing controlled substances via telehealth, does not apply to GLP-1 weight loss medications because they’re not classified as controlled substances. This is crucial to understand—while the Drug Enforcement Administration (DEA) has extended pandemic-era flexibilities for controlled medications like Adderall through December 31, 2025, these rules don’t affect your ability to get Wegovy or similar medications online.

Current Federal Status

As of December 2025, the DEA’s temporary telehealth flexibilities for controlled substances remain in effect, with expectations for further extension into 2026. However, for non-controlled medications like GLP-1 agonists, there have been no restrictions on telehealth prescribing at the federal level—before, during, or after the pandemic.

What matters most is establishing a valid patient-provider relationship, which federal guidelines define as a consultation using real-time audio and visual technology (typically a video call). A quick online questionnaire alone doesn’t cut it.

FDA Enforcement on Compounded Medications

One major change in 2025: the FDA declared the semaglutide shortage over and effectively banned routine compounding of these medications for weight loss as of May 22, 2025. This action shut down many telehealth companies that were offering cheaper, compounded versions of Wegovy or Ozempic.

If you’re considering telehealth for weight loss, ensure your provider prescribes FDA-approved medications from licensed pharmacies—not compounded alternatives that may lack quality controls and safety oversight.

State-by-State Variations: Where You Live Matters

While federal law allows telehealth prescribing of GLP-1 medications, state regulations add another layer of requirements. Your physical location during the telehealth visit determines which state’s rules apply, and these can vary significantly.

States Requiring Initial In-Person Visits

Several states mandate that patients undergo an in-person physical examination before or shortly after starting weight-loss medications via telehealth:

Arkansas: Known for having some of the strictest telemedicine regulations in the country, Arkansas requires an initial in-person exam to establish the patient-provider relationship before prescribing weight-loss medications.

Delaware: Requires an initial physical examination in person before telehealth prescribing can begin.

Georgia: State law mandates an in-person exam prior to prescribing weight-loss medications via telehealth, though 2024 legislation expanded what nurse practitioners can prescribe.

Mississippi: Requires patients to be seen in person at least once before continuing care via telehealth for weight management.

New Jersey: Perhaps the most comprehensive requirements—New Jersey mandates an extensive initial evaluation including a physical exam, laboratory work, psychological screening, and a documented diet and exercise plan before prescribing any weight-loss medication.

North Dakota: Expects a hands-on initial evaluation for weight-loss treatment per state medical board guidance.

South Carolina: State policy requires an initial in-person visit and periodic in-person evaluations for obesity treatment.

Texas: While telehealth is broadly allowed, the standard of care typically requires an initial in-person exam before prescribing weight-loss medications. Texas also has strict oversight of nurse practitioners and physician assistants, requiring physician delegation agreements.

Virginia: Requires a comprehensive work-up including physical exam, lab tests, and a personalized diet and exercise plan at the start, plus a follow-up visit within 30 days of beginning therapy.

States with No In-Person Requirements

Many states allow fully remote weight-loss treatment from start to finish, provided the telehealth evaluation meets professional standards:

California: Explicitly permits telehealth exams without requiring in-person visits for weight-loss medications. Nurse practitioners can practice independently after gaining experience.

Connecticut: No in-person mandate, but providers must include behavioral counseling and diet/exercise planning as part of obesity treatment.

Florida: While no in-person exam is federally required, Florida law imposes specific conditions: patients must have a BMI of 30 or higher and be seen (via telehealth or in person) at least every three months during treatment.

Illinois: Permanent telehealth law with no special in-person requirements for weight-loss prescribing beyond establishing a valid patient-provider relationship.

New York: Telehealth exam is sufficient with no in-person requirement. The state has mandatory e-prescribing for all medications.

Pennsylvania: No in-person mandate for GLP-1 medications via telehealth.

Utah: Generally no in-person requirement, though baseline evaluation is encouraged.

Washington: A pioneering telehealth state with no in-person restrictions. Washington’s My Health My Data Act adds privacy protections particularly relevant for sensitive weight-loss information.

Special State Requirements

Florida: Beyond the every-3-month visit requirement, Florida mandates that patients have a BMI of 30 or higher (or 27+ with weight-related health conditions) to qualify for obesity medications.

Connecticut: Requires that weight-loss treatment include behavioral counseling and documented diet and exercise plans.

Virginia: Mandates a follow-up appointment within 30 days of starting therapy and requires ongoing monitoring.

Who Can Prescribe Weight Loss Medications via Telehealth?

The type of provider you see during your telehealth visit depends on your state’s scope of practice laws:

Physicians (MDs and DOs)

All states allow licensed physicians to prescribe GLP-1 medications via telehealth, provided they’re licensed in the state where you’re located during the consultation.

Nurse Practitioners (NPs)

Nurse practitioner authority varies significantly by state:

Independent Practice States (34 states plus DC as of 2025): NPs can evaluate patients and prescribe weight-loss medications without physician oversight. Examples include California, New York, Washington, Arizona, Utah, and Virginia (after meeting experience requirements).

Collaborative Practice States: NPs can prescribe GLP-1 medications but must work under a physician collaboration or supervisory agreement. Examples include Florida, Georgia (recently expanded NP authority), Illinois, and Arkansas.

Restricted States: Very few states now significantly restrict NP prescribing, though Texas maintains strict oversight requiring formal physician delegation agreements for all prescriptive authority.

Physician Assistants (PAs)

PAs can prescribe weight-loss medications in all states, though most require some level of physician supervision or collaboration. The degree of independence varies, with some states allowing significant autonomy while others require more direct oversight.

At Klarity Health, all providers—whether physicians, nurse practitioners, or physician assistants—are fully licensed, credentialed, and authorized to practice in your state. You can feel confident that your telehealth provider meets all regulatory requirements.

Clinical Criteria: Who Qualifies for Weight Loss Medications?

Legitimate telehealth providers follow strict clinical guidelines when prescribing GLP-1 medications. You’ll generally need to meet these criteria:

BMI Requirements

• BMI of 30 or higher (clinical obesity), OR
• BMI of 27 or higher with at least one weight-related health condition such as:
• Type 2 diabetes
• High blood pressure
• High cholesterol
• Sleep apnea
• Cardiovascular disease risk factors

Medical Screening

Reputable telehealth providers will screen you for contraindications, including:

• Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current pregnancy or plans to become pregnant (you must stop GLP-1s before pregnancy)
• History of pancreatitis
• Severe gastroparesis or gastrointestinal disorders
• Active gallbladder disease
• History of eating disorders (may require additional evaluation)

Lifestyle Commitment

These medications aren’t magic pills. Providers will expect you to:

• Commit to dietary changes and portion control
• Increase physical activity as appropriate for your health status
• Attend regular follow-up appointments (typically monthly at first, then every 2–3 months)
• Monitor for side effects and report them promptly

Common Misconception: ‘I just want to lose 10 pounds for a wedding—can I get Ozempic online?’

Reputable providers won’t prescribe powerful GLP-1 medications for cosmetic weight loss or short-term goals. These are chronic disease medications intended for people with clinical obesity who need long-term management. If you don’t meet clinical criteria, legitimate telehealth services will recommend lifestyle modifications instead.

What to Expect from the Telehealth Process

Here’s how the typical telehealth weight-loss journey unfolds with a reputable provider:

1. Initial Assessment (30–45 minutes)

Your first telehealth appointment will include:

• Detailed medical history: Current and past health conditions, medications, allergies, surgical history
• Weight and health metrics: Self-reported weight, height, and health measurements (some providers send at-home scales or request recent measurements from your primary care doctor)
• Lifestyle assessment: Current eating patterns, physical activity level, previous weight loss attempts
• Mental health screening: History of eating disorders, depression, or other conditions that might affect treatment
• Discussion of goals: Realistic expectations, timeline, and commitment to lifestyle changes

2. Treatment Plan Development

If you qualify, your provider will:

• Explain which medication is recommended and why
• Review potential side effects and how to manage them
• Provide injection training (via video demonstration and written materials)
• Discuss the dosing schedule and titration plan
• Set follow-up appointments
• Send your prescription electronically to a pharmacy of your choice

3. Ongoing Monitoring

Follow-up appointments typically occur:

• 1 month after starting: Assess tolerance, side effects, and early results; adjust dose if needed
• Every 2–3 months thereafter: Monitor weight loss progress, check for side effects, evaluate labs if needed, adjust medication dose
• As needed for concerns: Contact your provider any time you experience concerning symptoms

Some states mandate specific follow-up intervals (Florida requires at least every 3 months; Virginia requires a check-in within 30 days of starting).

4. Laboratory Monitoring

While not always required before starting, many providers recommend baseline labs and periodic monitoring:

• Baseline: Comprehensive metabolic panel, A1C (if diabetic or prediabetic), thyroid function, lipid panel
• Follow-up: Metabolic panel every 6–12 months, A1C if diabetic, lipid panel to track cardiovascular benefits

Klarity Health: Your Partner in Safe Telehealth Weight Management

At Klarity Health, we understand that navigating weight loss treatment can feel overwhelming. That’s why we’ve built a telehealth platform that prioritizes safety, transparency, and personalized care.

What Sets Klarity Apart

Provider Availability: Access to licensed physicians and nurse practitioners across multiple states means you can get an appointment quickly—often within days rather than weeks.

Transparent Pricing: We accept both insurance and cash payment, with upfront pricing so there are no surprises. We believe healthcare costs should be clear and fair.

Comprehensive Care: Our providers don’t just write prescriptions. We partner with you to develop sustainable lifestyle changes, provide ongoing support, and adjust treatment based on your progress and needs.

State-Compliant Practice: Every Klarity provider is licensed in your state and follows all applicable regulations, including in-person exam requirements where mandated.

Quality Medications: We only prescribe FDA-approved medications dispensed through licensed pharmacies—never compounded or overseas alternatives of questionable quality.

When Klarity Might Recommend Against Medication

Our providers prioritize your long-term health over short-term profits. We may recommend against GLP-1 medications if:

• You don’t meet clinical BMI criteria
• You have contraindications that make these medications unsafe
• Your goals would be better served by lifestyle changes alone
• You’re not ready to commit to the necessary lifestyle modifications
• Another approach (like addressing an underlying thyroid condition or sleep disorder) should come first

This honest, patient-centered approach means you can trust that any recommendation we make is truly in your best interest.

Red Flags: How to Spot Disreputable Telehealth Services

Unfortunately, the popularity of GLP-1 medications has attracted some questionable operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions

Red Flag: ‘Everyone qualifies!’ or ‘Guaranteed prescription with purchase’

Reality: Legitimate providers can’t guarantee a prescription before evaluating you. Clinical criteria must be met, and some people won’t qualify for safety reasons.

No Medical Evaluation

Red Flag: Services that only require a brief questionnaire with no live video consultation

Reality: Federal and state laws require a proper patient-provider relationship, which means a real-time consultation with a licensed provider who can ask questions and assess your situation.

Compounded or Overseas Medications

Red Flag: Significantly cheaper ‘compounded semaglutide’ or medications shipped from overseas

Reality: The FDA banned routine compounding of these medications in 2025. Overseas sources may sell counterfeit or contaminated products. Stick with FDA-approved medications from U.S. licensed pharmacies.

No Follow-Up Required

Red Flag: ‘Get your prescription and we’ll refill it automatically—no check-ins needed’

Reality: These powerful medications require monitoring. Regular follow-ups aren’t just good practice—they’re medically necessary and required by law in many states.

Unclear Provider Credentials

Red Flag: No information about who will see you, their credentials, or what state they’re licensed in

Reality: You have a right to know your provider’s qualifications and verify they’re licensed to practice in your state.

Waiving Your Rights

Red Flag: Agreements that make you waive liability or acknowledge the service isn’t ‘medical care’

Reality: Legitimate telehealth is real medical care with the same standards and accountability as in-person visits.

Insurance Coverage and Costs

One of the most common questions about telehealth weight-loss treatment is: ‘Will my insurance cover this?’

Insurance Coverage for GLP-1 Medications

Coverage varies widely by insurance plan:

Medicare: Generally covers GLP-1s for diabetes but not for weight loss alone (though this may change with pending legislation)

Medicaid: Coverage varies by state; some cover obesity medications while others don’t

Commercial Insurance: Many plans now cover weight-loss medications, especially if you have obesity-related health conditions, but coverage criteria and prior authorization requirements vary significantly

Important: Even when medications are covered, insurers often require:

• Documentation of BMI over 30 (or 27+ with comorbidities)
• Evidence of previous weight-loss attempts
• Prior authorization from your provider
• Step therapy (trying other treatments first)

Cost Without Insurance

If paying out of pocket, expect:

• Wegovy: $1,300–$1,500 per month without insurance (though manufacturer savings programs may reduce this)
• Ozempic: $900–$1,000 per month (if used off-label for weight loss)
• Mounjaro/Zepbound: $1,000–$1,200 per month

Klarity Health accepts both insurance and self-pay patients, with transparent pricing for consultations and clear information about medication costs upfront. We’ll help you navigate insurance coverage and explore patient assistance programs when available.

Common Side Effects and Safety Considerations

Like all medications, GLP-1 agonists can cause side effects. Your telehealth provider will discuss these in detail, but here’s what to expect:

Common Side Effects (Often Temporary)

• Nausea (usually improves after the first few weeks)
• Diarrhea or constipation
• Decreased appetite (this is therapeutic but can feel uncomfortable initially)
• Fatigue
• Headache
• Abdominal discomfort or bloating

Serious Side Effects (Rare but Important)

• Pancreatitis (severe abdominal pain that radiates to the back)
• Gallbladder problems (upper right abdominal pain, especially after eating)
• Kidney problems (especially if you become dehydrated from vomiting/diarrhea)
• Changes in vision (if diabetic)
• Increased heart rate
• Thyroid tumors (animal studies showed increased risk; unknown in humans)

When to contact your provider immediately: Severe abdominal pain, persistent vomiting, signs of pancreatitis, allergic reactions, or any symptom that concerns you.

Your telehealth provider will review warning signs during your initial visit and should be available for questions between appointments. This ongoing accessibility is one of the key advantages of quality telehealth platforms like Klarity.

Frequently Asked Questions

Q: Can I get Ozempic online if I don’t have diabetes?

A: Technically, yes—providers can prescribe Ozempic off-label for weight loss if you meet clinical criteria. However, you’ll need to have obesity (BMI ≥30) or be overweight (BMI ≥27) with weight-related health conditions. Your provider must document the off-label use and obtain your informed consent. Many providers prefer to prescribe Wegovy for weight loss since it’s FDA-approved for that purpose.

Q: Do I need to see my regular doctor first before using telehealth for weight loss?

A: Not necessarily. Telehealth providers can serve as your primary source of care for weight management. However, it’s good practice to keep your primary care doctor informed, especially if you have other health conditions they’re managing. Some states require an in-person exam, which your regular doctor could provide if your state mandates it.

Q: How long will I need to stay on these medications?

A: GLP-1 medications for obesity are typically long-term treatments. Studies show that most people regain weight when they stop, so these should be viewed as chronic disease management similar to blood pressure or cholesterol medications. Your provider will monitor your progress and adjust the plan as needed, but expect to stay on treatment as long as it’s safe, effective, and beneficial.

Q: What if I move to a different state during treatment?

A: Your telehealth provider must be licensed in the state where you’re physically located during appointments. If you move, you’ll need to notify your provider. They may be able to continue care if they’re licensed in your new state, or they’ll need to transfer your care to a provider who is. Many telehealth platforms like Klarity have providers licensed in multiple states to handle this situation.

Q: Can I use telehealth to get these medications if I live in a rural area?

A: Absolutely—telehealth is especially valuable for people in rural or underserved areas where specialized weight management care may not be easily accessible. As long as you have internet access for video calls, you can receive the same quality care as someone in a major city.

Q: Are online pharmacies that offer ‘semaglutide’ without a prescription legitimate?

A: No. Any pharmacy or service offering prescription medications without a valid prescription from a licensed provider is operating illegally and likely selling counterfeit, contaminated, or improperly stored medications. Always get your medications through legitimate telehealth providers and licensed U.S. pharmacies.

The Future of Telehealth Weight Management

The landscape of telehealth weight-loss treatment continues to evolve. Here’s what we’re watching:

Pending Federal Legislation

The TREATS Act, reintroduced in October 2025, could make permanent some telehealth flexibilities for prescribing controlled substances. While this doesn’t directly affect GLP-1 medications (which aren’t controlled), it signals growing Congressional support for expanding telehealth access across all areas of medicine.

State Law Trends

More states are moving toward full practice authority for nurse practitioners, which will increase access to telehealth weight management services. Bills pending in Mississippi, Pennsylvania, and other states could expand who can independently prescribe these medications in 2026.

New Medications on the Horizon

The pipeline of anti-obesity medications continues to grow, with new GLP-1 agonists and combination therapies in development. Telehealth providers will play a crucial role in making these treatments accessible as they receive FDA approval.

Insurance Coverage Expansion

As evidence mounts for the long-term health benefits of treating obesity (reduced diabetes risk, cardiovascular benefits, etc.), more insurers are expanding coverage for weight-loss medications. Medicare coverage for obesity medications has bipartisan support in Congress and could become reality in 2026 or 2027.

Taking the Next Step

If you’re struggling with obesity and considering telehealth treatment, now is a great time to explore your options. The regulatory framework is clearer than ever, access is expanding, and the safety and efficacy of GLP-1 medications are well-established.

Ready to start your weight loss journey with expert support? Klarity Health makes it easy to connect with licensed providers who can evaluate your situation, explain your options, and develop a personalized treatment plan that fits your life. With provider availability across multiple states, transparent pricing, and comprehensive ongoing care, we’re here to support you every step of the way.

Don’t let confusion about regulations or fear of online services hold you back from getting the help you need. When you choose a reputable telehealth provider like Klarity, you’re choosing safe, legal, convenient access to evidence-based weight management care.

Schedule your confidential consultation with Klarity Health today and take the first step toward sustainable weight loss with the support of experienced, licensed healthcare providers who understand both the medical and emotional aspects of weight management.

Citations

1. Drug Enforcement Administration. (2024, November 15). DEA and HHS Extend Telemedicine Flexibilities through 2025. Retrieved from https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. McDermott Will & Emery. (2024, November 18). DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025. Retrieved from https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/

3. Goodwin Procter LLP. (2024, March 27). The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs. Retrieved from https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs

4. Reuters. (2025, May 30). Hims to cut 4% of workforce amid ban on weight-loss drug copies. Retrieved from https://www.reuters.com/business/healthcare-pharmaceuticals/hims-cut-4-workforce-amid-ban-weight-loss-drug-copies-2025-05-30/

5. Nextech. (2025, April 11). Know Your State’s Laws Around Semaglutide. Retrieved from https://www.nextech.com/blog/semaglutide-laws-by-state

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid